Plain-English translation of NCT07509125 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are using a cutting-edge brain scanner called NeuroExplorer PET to take very detailed pictures of the brain and spinal cord. This trial aims to understand how healthy brains age and how brains change in diseases like Alzheimer's, Parkinson's, ALS, and psychotic disorders. By studying these detailed images, doctors hope to find early warning signs that could help diagnose and treat these diseases sooner.
Currently, standard brain imaging cannot see small but important brain structures clearly enough to spot early disease changes. This trial is trying to fill that gap by using advanced imaging technology to identify biomarkers—early signs of disease—before symptoms become severe, which could lead to better diagnosis and treatment in the future.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will undergo brain and spinal cord imaging scans using the new NeuroExplorer PET scanner, along with standard MRI scans. You will also complete memory and thinking tests, and answer questions about your mood, movement, or psychiatric symptoms depending on your group. The study team may ask you to donate a blood sample. The exact number of visits and scans will depend on which group you join, but participants should expect multiple visits to the research center.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Belgium